Frozen Blood Bags
Closed Special Notice Posted
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- Camp Lejeune, North Carolina 28547, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency, through its Healthcare Contracting Division–Southeast, issued a Notice of Intent on August 27, 2026 to execute a sole-source contract with Fenwal, Inc., a Fresenius Kabi Company, for frozen blood bags under FAR 6.103-1, citing only one responsible source capable of satisfying agency requirements.
Naval Medical Center Camp Lejeune's Blood Donor Center requires CPDA triple blood bags and Glycerolyte 57% Solution configured and validated for use with the Haemonetics ACP 215s and AMICUS Separator Collection System currently in inventory at the facility. All supplies must be FDA-approved for patient care and free of defects in accordance with FDA regulations and federal and industry standards. The delivery period runs October 1, 2026 through September 30, 2027, with timely delivery required.
The procurement is classified under NAICS 339112 (Surgical and Medical Instrument Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies). No set-aside restrictions apply. The SBA size standard for this category is 1,000 employees. This Notice of Intent satisfies FAR Part 5.101 posting requirements and is not a request for competitive proposals; no solicitation package is available.
Notice text
This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. No solicitation package is available, and telephone requests will not be honored. Only one responsible source, and no other supplies or services will satisfy agency requirements.
The Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division- Southeast (HCD-Southeast) is issuing this Notice of Intent (NOI) to inform industry contractors of the Government’s intent to execute a Sole Source contract under FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This notice satisfies posting requirements at FAR Part 5.101. The proposed source is Fenwal, Inc., a Fresenius Kabi Company (Fenwal) of Three Corporate Drive, Lake Zurich, IL 60047.
The Naval Medical Center Camp Lejeune (NMCCL), NC Blood Donor Center has a requirement for CPDA triple blood bags and Glycerolyte 57% Solution. The requested items shall be configured and validated for use with the Haemonetic ACP 215s that NMCCL currently owns. The items shall be Food and Drug Administration (FDA) approved for patient care. The requested supplies shall be configured and validated for use with the AMICUS™ Separator Collection System that NMCCL currently owns. The supplies shall be delivered timely, and products shall be free of defects in accordance with federal and industry standards per Food and Drug Administration (FDA) regulations.
The supplies shall be provided for a delivery period from 01 October 2026 – 30 September 2027.
There are no set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 339112- Surgical and Medical Instrument Manufacturing. The Product/Service Code (PSC): 6515- Medical and surgical instruments, equipment, and supplies. The Small Business Administration (SBA) size standard is 1,000 employees.
Parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same supplies or services. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF or MS Word, shall not exceed 3 (8.5 x 11 inch) pages using a font size no smaller than 11-point.) to Koffi Alognon at koffi.e.alognon.civ@health.mil . Closing date for challenges is no later than 10:00 AM ET on Tuesday, 01 September 2026. No phone calls will be accepted.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6506--Notice of Intent to Sole Source - Lab Supplies (Blood) Altoona VA Medical Center, Altoona, PA | Veterans Integrated Service Network 4 | No set-aside | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside | |
| PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood | Defense Health Agency | No set-aside | |
| Sepsis Research Blood Sample Collection Services | — | No set-aside | |
| Autonomous Portable blood Refrigeration Unit | MICC Fort Drum | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity